Gabbi, the risk assessment and care navigation company, today announced it has raised a round of $4.4M to help tackle its mission of ensuring breast cancer is detected at the earliest possible stages when it is a treatable, survivable disease. Bread and Butter Ventures led the round which also saw participation from Female Founders Fund, WR Hambrecht, Phoenix Rising, Claridge Ventures Advisors VC, Coyote…
Following a year in which Vara expanded into international markets like Greece and Mexico, the deeptech startup today announces that it has raised a further €4.5 million to continue international expansion. The extension, which takes the total Series A funding raised to €11 million, was led by VI Partners and included impact investor, EQT Foundation, as well as the family office behind one…
Forty percent of women in the U.S. have dense breast tissue, and they have a 4-6 times greater risk of developing breast cancer. Mammography alone misses about half the cancers in women with dense breasts, as dense tissue and cancer both appear white on mammogram images. Delphinus Medical Technology‘s SoftVue System is indicated for use as an adjunct to digital mammography in…
Singapore-based digital health AI company FathomX, a spin-off company from the National University of Singapore (NUS) and National University Health System (NUHS), recently raised a Pre-series A fund of SGD $2.24M (ca. USD $2M) the lead up to Series A funding. Fathom X raised SGD$ 500K (ca. USD$ 350K) in a seed round in April 2021. Additionally, the I2Start Funding Program, a tripartite initiative to support company…
iSono Health has announced U.S. Food and Drug Administration (FDA) clearance of the company’s ATUSA System for breast imaging, a first-of-its-kind compact automated whole breast ultrasound system featuring a unique wearable accessory and an intuitive software for automated image acquisition and analysis. Designed to offer enhanced efficiency, consistent accuracy and a comfortable patient experience, ATUSA’s patented technology makes 3D breast ultrasound imaging…
German deeptech startup Vara has developed an AI-powered platform for radiologists that combines the strengths of humans and of AI to make both better. Today the company supplies AI technology to over 20% of German breast cancer screening units and in 2022 it is now getting serious about internationalization. To kick off this expansion Vara has joined forces with Argentinian healthtech company…
Whiterabbit, an AI technology company focused on early breast cancer detection, has announced a new partnership with Solis Mammography, one of the largest independent providers of breast health and diagnostic services in the United States. After pilots in multiple markets demonstrated improvement in screening mammography bookings and patient compliance, the company implemented the ACT product at more than 70 centers. Through this…
Therapixel has received a second 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MammoScreen, AI-based software assisting radiologists in breast cancer screening. This new clearance expands the use of Mammoscreen to Digital Breast Tomosynthesis (3D Mammography). Therapixel is a French company specialized in the design and commercialization of AI-powered medical imaging software, with the goal of delivering pertinent information…
